Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0000950170-25-011335

See remarks sold 45,464 shares at an average $4.50 ($204,753)

  • See remarks acquired 139,141 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Rahmer Peter See remarks 2025-01-28 Sale −1,673 $4.63 $7,746 307,081 D: show line 1 in the form
Rahmer Peter See remarks 2025-01-28 Grant or award +139,141 446,222 D: show line 2 in the form
Rahmer Peter See remarks 2025-01-29 Sale −26,541 $4.55 $120,762 419,681 D: show line 3 in the form
Rahmer Peter See remarks 2025-01-30 Sale −17,250 $4.42 $76,245 402,431 D: show line 4 in the form
Open-market sales · 45,464 sh · avg $4.50 · $204,753
Loading xslF345X05/ownership.xml…